Bioaffinity Has Acquired Laboratory Assets Of Village Oaks Pathology Services, d/b/a Precision Pathology Services, A Clinical Laboratory For $3.5M Including $2.5M In Cash And $1M In Bioaffinity Stock
Portfolio Pulse from Benzinga Newsdesk
Bioaffinity has acquired the laboratory assets of Village Oaks Pathology Services, also known as Precision Pathology Services, a clinical laboratory for $3.5M. The deal includes $2.5M in cash and $1M in Bioaffinity stock.
September 19, 2023 | 12:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bioaffinity's acquisition of Precision Pathology Services' lab assets could potentially expand its service offerings and increase its market share.
The acquisition of Precision Pathology Services' lab assets by Bioaffinity could potentially expand its service offerings and increase its market share. This could lead to increased revenues and profitability in the future, which could positively impact the company's stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100